Understanding PTPN2's Role in Gut Health and Autoimmune Conditions
A Novel Role for PTPN2 in Intestinal Epithelial Barrier Regulation
This project explores how a gene called PTPN2 helps maintain a healthy gut barrier and balance gut microbes, which is important for conditions like IBD, celiac disease, and Type 1 diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project ID | NIH-11089399 on NIH RePORTER |
What this research studies
Our bodies rely on a strong intestinal barrier and balanced gut microbes to prevent diseases like Inflammatory Bowel Disease, celiac disease, and Type 1 diabetes. We are looking closely at a specific gene, PTPN2, because changes in this gene are linked to these conditions and can affect the types of bacteria living in the gut. We believe PTPN2 acts as a "microbial modulator" by helping the gut's protective cells, called Paneth cells, produce substances that fight off harmful bacteria and maintain a healthy environment. By understanding how PTPN2 works, we hope to uncover new ways to protect the intestine from bacterial imbalances that contribute to these autoimmune diseases.
Who could benefit from this research
Good fit: Patients with autoinflammatory diseases such as Inflammatory Bowel Disease, celiac disease, or Type 1 diabetes, especially those with known PTPN2 gene variations, might ultimately benefit from this research.
Not a fit: Patients without autoinflammatory conditions or those whose conditions are not related to intestinal barrier function or microbial imbalances may not directly benefit from this specific line of research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to prevent or treat autoinflammatory diseases by targeting the PTPN2 gene or its related pathways to improve gut barrier function and microbial balance.
How similar studies have performed: Research has previously linked genetic factors and gut microbiome changes to autoinflammatory diseases, and the role of PTPN2 has been identified in patient cohorts, suggesting a promising direction for this work.
Where this research is happening
Riverside, United States
- University of California Riverside — Riverside, United States (Active)
Researchers
- Principal investigator: Mccole, Declan — University of California Riverside
- Study coordinator: Mccole, Declan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.